{"abstracts-retrieval-response": {"item": {"ait:process-info": {"ait:status": {"@state": "update", "@type": "core", "@stage": "S300"}, "ait:date-delivered": {"@day": "19", "@year": "2019", "@timestamp": "2019-12-19T01:00:25.000025-05:00", "@month": "12"}, "ait:date-sort": {"@day": "30", "@year": "2015", "@month": "12"}}, "bibrecord": {"head": {"author-group": {"affiliation": {"country": "Thailand", "postal-code": "10330", "@afid": "60028190", "@country": "tha", "city": "Bangkok", "organization": [{"$": "International Graduate Program in Social and Administrative Pharmacy"}, {"$": "Faculty of Pharmaceutical Sciences"}, {"$": "Chulalongkorn University"}], "affiliation-id": {"@afid": "60028190"}}, "author": [{"ce:given-name": "Wanida", "preferred-name": {"ce:given-name": "Wanida", "ce:initials": "W.", "ce:surname": "Kaewpanukrungsi", "ce:indexed-name": "Kaewpanukrungsi W."}, "@seq": "1", "ce:initials": "W.", "@_fa": "true", "@type": "auth", "ce:surname": "Kaewpanukrungsi", "@auid": "57053289400", "ce:indexed-name": "Kaewpanukrungsi W."}, {"ce:given-name": "Puree", "preferred-name": {"ce:given-name": "Puree", "ce:initials": "P.", "ce:surname": "Anantachoti", "ce:indexed-name": "Anantachoti P."}, "@seq": "2", "ce:initials": "P.", "@_fa": "true", "@type": "auth", "ce:surname": "Anantachoti", "@auid": "6506845858", "ce:indexed-name": "Anantachoti P."}]}, "citation-title": "Performance assessment of the Thai National Center for Pharmacovigilance", "abstracts": "\u00a9 2015 IOS Press and the authors.BACKGROUND: The Thai National Pharmacovigilance Center (NPVC) has operated since 1983, but its performance has never been formally assessed. OBJECTIVE: The paper aimed to present the main findings of performance assessment of the Thai NPVC. METHODS: A survey was conducted. Data from January 2011-December 2013 were collected. The performance was assessed through four indicator domains. RESULTS: The NPVC has a clear mission to guide its roles and responsibilities. The center has a well-established structure, adequate budget, qualified personnel, and good IT infrastructure, but it has no in-house IT personnel. Safety surveillance function was considered excellent. The Thai adverse drug reaction database accumulate a number of quality reports. Typically, new signals of traditional or herbal medicines could be generated from the database. The risk management process was well established and carried out. The National Drug Safety Advisory Sub-Committee was composed of qualified representatives from related disciplines. Not only do these committee members make safety decisions, but they also provide key safety messages and communicate these to their member audiences. The risk communication function was evaluated to be unsatisfactory. It was not effectively distributed to individual health care professionals. CONCLUSIONS: The overall performance of the Thai NPVC was considerably good. The findings suggested that risk communication should be improved. Moreover, organizational performance should be routinely evaluated. If possible, benchmarking with international pharmacovigilance centers should also be performed.", "correspondence": {"affiliation": {"country": "Thailand", "postal-code": "10330", "@country": "tha", "city": "Bangkok", "organization": [{"$": "International Graduate Program in Social and Administrative Pharmacy"}, {"$": "Faculty of Pharmaceutical Sciences"}, {"$": "Chulalongkorn University"}]}, "person": {"ce:given-name": "Puree", "ce:initials": "P.", "ce:surname": "Anantachoti", "ce:indexed-name": "Anantachoti P."}}, "citation-info": {"author-keywords": {"author-keyword": [{"$": "indicators", "@xml:lang": "eng"}, {"$": "performance assessment", "@xml:lang": "eng"}, {"$": "Pharmacovigilance (PV)", "@xml:lang": "eng"}, {"$": "the Thai National Pharmacovigilance Center (Thai NPVC)", "@xml:lang": "eng"}]}, "citation-type": {"@code": "ar"}, "citation-language": {"@language": "English", "@xml:lang": "eng"}, "abstract-language": {"@language": "English", "@xml:lang": "eng"}}, "source": {"website": {"ce:e-address": {"$": "www.iospress.nl/site/html/09246479.html", "@type": "email"}}, "translated-sourcetitle": {"$": "International Journal of Risk and Safety in Medicine", "@xml:lang": "eng"}, "volisspag": {"voliss": {"@volume": "27", "@issue": "4"}, "pagerange": {"@first": "225", "@last": "237"}}, "@type": "j", "sourcetitle": "International Journal of Risk and Safety in Medicine", "publicationdate": {"month": "12", "year": "2015", "date-text": {"@xfab-added": "true", "$": "30 December 2015"}, "day": "30"}, "codencode": "IJMDE", "sourcetitle-abbrev": "Int. J. Risk Saf. Med.", "@country": "nld", "issn": [{"$": "18786847", "@type": "electronic"}, {"$": "09246479", "@type": "print"}], "publicationyear": {"@first": "2015"}, "publisher": {"affiliation": {"address-part": "Nieuwe Hemweg 6B", "postal-code": "1013 BG", "@country": "nld", "city": "Amsterdam"}, "publishername": "IOS Press"}, "@srcid": "18161"}, "enhancement": {"classificationgroup": {"classifications": [{"@type": "CABSCLASS", "classification": {"classification-code": "99", "classification-description": "General"}}, {"@type": "EMCLASS", "classification": {"classification-code": "17", "classification-description": "Public Health, Social Medicine and Epidemiology"}}, {"@type": "ASJC", "classification": [{"$": "2719"}, {"$": "2739"}]}, {"@type": "SUBJABBR", "classification": "MEDI"}]}}}, "item-info": {"copyright": {"$": "Copyright 2017 Elsevier B.V., All rights reserved.", "@type": "Elsevier"}, "dbcollection": [{"$": "CABS"}, {"$": "EMBASE"}, {"$": "MEDL"}, {"$": "NURSNG"}, {"$": "REAXYSCAR"}, {"$": "SCOPUS"}, {"$": "Scopusbase"}], "history": {"date-created": {"@day": "10", "@year": "2017", "@timestamp": "BST 17:04:23", "@month": "05"}}, "itemidlist": {"itemid": [{"$": "607734172", "@idtype": "PUI"}, {"$": "2016017850", "@idtype": "CABS"}, {"$": "644227021", "@idtype": "CAR-ID"}, {"$": "20160039461", "@idtype": "EMBASE"}, {"$": "26756896", "@idtype": "MEDL"}, {"$": "2016018193", "@idtype": "NURSNG"}, {"$": "2016230140", "@idtype": "REAXYSCAR"}, {"$": "84954145694", "@idtype": "SCP"}, {"$": "84954145694", "@idtype": "SGR"}, {"$": "616000721", "@idtype": "PUIsecondary"}], "ce:doi": "10.3233/JRS-150663"}}, "tail": {"bibliography": {"@refcount": "14", "reference": [{"ref-fulltext": "World Health Organization. Pharmacovigilance: Ensuring the safe use of medicines. Geneva, Switzerland; 2004", "@id": "1", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "refd-itemidlist": {"itemid": {"$": "21244431953", "@idtype": "SGR"}}, "ref-text": "World Health Organization. Geneva, Switzerland", "ref-sourcetitle": "Pharmacovigilance: Ensuring the Safe Use of Medicines"}}, {"ref-fulltext": "Dal Pan GJ. Ongoing Challenges in Pharmacovigilance. Drug Safety. 2014; 37: 1-8", "@id": "2", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Ongoing challenges in pharmacovigilance"}, "refd-itemidlist": {"itemid": {"$": "84896691054", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "37"}, "pagerange": {"@first": "1", "@last": "8"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "G.J.", "@_fa": "true", "ce:surname": "Dal Pan", "ce:indexed-name": "Dal Pan G.J."}]}, "ref-sourcetitle": "Drug Safety"}}, {"ref-fulltext": "Lusthaus C, Adrien M-H, Anderson G, Carden F, Montalvan GP. Organizational assessment: A framework for improving performance. The International Development Research Centre, Ottawa, Canada/ the Inter-American Development Bank, Washington, D.C., USA; 2002 [Online; cited 2010 May]. Available from: http://www.idrc.ca/booktique", "@id": "3", "ref-info": {"ref-publicationyear": {"@first": "2002"}, "ref-website": {"ce:e-address": {"$": "http://www.idrc.ca/booktique", "@type": "email"}}, "ref-title": {"ref-titletext": "Organizational assessment: A framework for improving performance"}, "refd-itemidlist": {"itemid": {"$": "34250203486", "@idtype": "SGR"}}, "ref-text": "Washington D.C. USA [Online; cited 2010 May]. Available from", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Lusthaus", "ce:indexed-name": "Lusthaus C."}, {"@seq": "2", "ce:initials": "M.-H.", "@_fa": "true", "ce:surname": "Adrien", "ce:indexed-name": "Adrien M.-H."}, {"@seq": "3", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Anderson", "ce:indexed-name": "Anderson G."}, {"@seq": "4", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Carden", "ce:indexed-name": "Carden F."}, {"@seq": "5", "ce:initials": "G.P.", "@_fa": "true", "ce:surname": "Montalvan", "ce:indexed-name": "Montalvan G.P."}]}, "ref-sourcetitle": "International Development Research Centre Ottawa Canada/ the Inter-American Development Bank"}}, {"ref-fulltext": "National Drug Policy (in Thai), the office of National Drug System Development Committee, Bureau of drug control, Food and Drug Administration, Nonthaburi, Thailand; 2011", "@id": "4", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "refd-itemidlist": {"itemid": {"$": "85018221316", "@idtype": "SGR"}}, "ref-sourcetitle": "National Drug Policy (In Thai) the Office of National Drug System Development Committee, Bureau of Drug Control, Food and Drug Administration, Nonthaburi, Thailand"}}, {"ref-fulltext": "Guideline for Safety Monitoring Program (in Thai), Food and Drug Administration, Nonthaburi, Thailand; [Updated 2012].", "@id": "5", "ref-info": {"refd-itemidlist": {"itemid": {"$": "84954134466", "@idtype": "SGR"}}, "ref-text": "Nonthaburi, Thailand; [Updated 2012]", "ref-sourcetitle": "Guideline for Safety Monitoring Program (In Thai), Food and Drug Administration"}}, {"ref-fulltext": "Meyboom RHB, EgbertsACG, Gribnau FWJ, HeksterYA. Pharmacovigilance in Perspective. Drug Safety. 1999; 21(6): 429-447", "@id": "6", "ref-info": {"ref-publicationyear": {"@first": "1999"}, "ref-title": {"ref-titletext": "Pharmacovigilance in perspective"}, "refd-itemidlist": {"itemid": {"$": "0033376337", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "21", "@issue": "6"}, "pagerange": {"@first": "429", "@last": "447"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.H.B.", "@_fa": "true", "ce:surname": "Meyboom", "ce:indexed-name": "Meyboom R.H.B."}, {"@seq": "2", "ce:initials": "A.C.G.", "@_fa": "true", "ce:surname": "Egberts", "ce:indexed-name": "Egberts A.C.G."}, {"@seq": "3", "ce:initials": "F.W.J.", "@_fa": "true", "ce:surname": "Gribnau", "ce:indexed-name": "Gribnau F.W.J."}, {"@seq": "4", "ce:initials": "Y.A.", "@_fa": "true", "ce:surname": "Hekster", "ce:indexed-name": "Hekster Y.A."}]}, "ref-sourcetitle": "Drug Safety"}}, {"ref-fulltext": "Lindquist M. Use of Triage Strategies in the WHO Signal-Detection Process. Drug Safety. 2007; 30(7): 635-637", "@id": "7", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Use of triage strategies in the who signal-detection process"}, "refd-itemidlist": {"itemid": {"$": "34447128818", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "30", "@issue": "7"}, "pagerange": {"@first": "635", "@last": "637"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Lindquist", "ce:indexed-name": "Lindquist M."}]}, "ref-sourcetitle": "Drug Safety"}}, {"ref-fulltext": "Palaian S, Ibrahim MIM, Mishra P, Alam K, Shankar PR, Thapa BB. Pharmacovigilance Activities in Nepal. Drug Safety. 2010; 33(10): 889-890", "@id": "8", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Pharmacovigilance activities in Nepal"}, "refd-itemidlist": {"itemid": {"$": "77956323093", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "33", "@issue": "10"}, "pagerange": {"@first": "889", "@last": "890"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Palaian", "ce:indexed-name": "Palaian S."}, {"@seq": "2", "ce:initials": "I.", "@_fa": "true", "ce:surname": "Mim", "ce:indexed-name": "Mim I."}, {"@seq": "3", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Mishra", "ce:indexed-name": "Mishra P."}, {"@seq": "4", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Alam", "ce:indexed-name": "Alam K."}, {"@seq": "5", "ce:initials": "P.R.", "@_fa": "true", "ce:surname": "Shankar", "ce:indexed-name": "Shankar P.R."}, {"@seq": "6", "ce:initials": "B.B.", "@_fa": "true", "ce:surname": "Thapa", "ce:indexed-name": "Thapa B.B."}]}, "ref-sourcetitle": "Drug Safety"}}, {"ref-fulltext": "Bahri P, Mol PGM, Theophile H, Edwards IR, Hugman BPJ. Communication in Drug Safety: A Report from an Interactive Debate Held at the 10th Annual Meeting of the International Society of Pharmacovigilance (ISoP), 2010. Drug Safety. 2011; 34(10): 881-882", "@id": "9", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Communication in drug safety: A report from an interactive debate held at the 10th annual meeting of the international society of pharmacovigilance (isop) 2010"}, "refd-itemidlist": {"itemid": {"$": "80052328238", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "34", "@issue": "10"}, "pagerange": {"@first": "881", "@last": "882"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Bahri", "ce:indexed-name": "Bahri P."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Pgm", "ce:indexed-name": "Pgm M."}, {"@seq": "3", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Theophile", "ce:indexed-name": "Theophile H."}, {"@seq": "4", "ce:initials": "I.R.", "@_fa": "true", "ce:surname": "Edwards", "ce:indexed-name": "Edwards I.R."}, {"@seq": "5", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Bpj", "ce:indexed-name": "Bpj H."}]}, "ref-sourcetitle": "Drug Safety"}}, {"ref-fulltext": "Olsson S, Pal SN, Stergachis A, Couper M. Pharmacovigilance activities in 55 low-And middle-income countries: A questionnaire-based analysis. Drug Safety. 2010; 33(8): 689-703", "@id": "10", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Pharmacovigilance activities in 55 low-And middle-income countries: A questionnaire-based analysis"}, "refd-itemidlist": {"itemid": {"$": "77954724803", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "33", "@issue": "8"}, "pagerange": {"@first": "689", "@last": "703"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Olsson", "ce:indexed-name": "Olsson S."}, {"@seq": "2", "ce:initials": "S.N.", "@_fa": "true", "ce:surname": "Pal", "ce:indexed-name": "Pal S.N."}, {"@seq": "3", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Stergachis", "ce:indexed-name": "Stergachis A."}, {"@seq": "4", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Couper", "ce:indexed-name": "Couper M."}]}, "ref-sourcetitle": "Drug Safety"}}, {"ref-fulltext": "Piper D, Stein-Seroussi A, Flewelling R, Orwin RG, Buchanan R. Assessing state substance abuse prevention infrastructure through the lens of CSAP?s Strategic Prevention framework. Evaluation and Program Planning. 2012; 35: 66-77", "@id": "11", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Assessing state substance abuse prevention infrastructure through the lens of CSAP?s Strategic Prevention framework"}, "refd-itemidlist": {"itemid": {"$": "80052034143", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "35"}, "pagerange": {"@first": "66", "@last": "77"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Piper", "ce:indexed-name": "Piper D."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Stein-Seroussi", "ce:indexed-name": "Stein-Seroussi A."}, {"@seq": "3", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Flewelling", "ce:indexed-name": "Flewelling R."}, {"@seq": "4", "ce:initials": "R.G.", "@_fa": "true", "ce:surname": "Orwin", "ce:indexed-name": "Orwin R.G."}, {"@seq": "5", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Buchanan", "ce:indexed-name": "Buchanan R."}]}, "ref-sourcetitle": "Evaluation and Program Planning"}}, {"ref-fulltext": "World Health Organization. Minimum Requirements for a functional Pharmacovigilance System. Geneva, Switzerland; 2013 [Online; cited 2014 March ]. Available from: www.who.int/medicines/areas/quality safety/safety efficacy/saf pub/en/.", "@id": "12", "ref-info": {"ref-website": {"ce:e-address": {"$": "www.who.int/medicines/areas/qualitysafety/safetyefficacy/safpub/en/", "@type": "email"}}, "refd-itemidlist": {"itemid": {"$": "84896098419", "@idtype": "SGR"}}, "ref-text": "World Health Organization. Geneva, Switzerland 2013 [Online; cited 2014 March ]. Available from", "ref-sourcetitle": "Minimum Requirements for A Functional Pharmacovigilance System"}}, {"ref-fulltext": "Groene O, Klazinga N, Kazandjian V, Lombrail P, Bartels P. The World Health Organization Performance Assessment Tool for Quality Improvement in Hospitals (PATH): An Analysis of the Pilot Implementation in 37 Hospitals. Int J for Quality in Health Care. 2008; 20(3): 155-161", "@id": "13", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "The world health organization performance assessment tool for quality improvement in hospitals (path): An analysis of the pilot implementation in 37 hospitals"}, "refd-itemidlist": {"itemid": {"$": "44449109546", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "20", "@issue": "3"}, "pagerange": {"@first": "155", "@last": "161"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "O.", "@_fa": "true", "ce:surname": "Groene", "ce:indexed-name": "Groene O."}, {"@seq": "2", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Klazinga", "ce:indexed-name": "Klazinga N."}, {"@seq": "3", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Kazandjian", "ce:indexed-name": "Kazandjian V."}, {"@seq": "4", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Lombrail", "ce:indexed-name": "Lombrail P."}, {"@seq": "5", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Bartels", "ce:indexed-name": "Bartels P."}]}, "ref-sourcetitle": "Int J for Quality in Health Care"}}, {"ref-fulltext": "Kates J, Marconi K, Mannle JrTE. Developing a performance management system for a Federal public health program: The Ryan White CARE Act Titles I and II. Evaluation and Program Planning. 2001; 24: 145-155", "@id": "14", "ref-info": {"ref-publicationyear": {"@first": "2001"}, "ref-title": {"ref-titletext": "Developing a performance management system for a Federal public health program: The ryan white care act titles i and II"}, "refd-itemidlist": {"itemid": {"$": "0010962628", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "24"}, "pagerange": {"@first": "145", "@last": "155"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Kates", "ce:indexed-name": "Kates J."}, {"@seq": "2", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Marconi", "ce:indexed-name": "Marconi K."}, {"@seq": "3", "ce:initials": "T.E.", "@_fa": "true", "ce:surname": "Mannle", "ce:suffix": "Jr.", "ce:indexed-name": "Mannle T.E."}]}, "ref-sourcetitle": "Evaluation and Program Planning"}}]}}}}, "affiliation": {"affiliation-city": "Bangkok", "@id": "60028190", "affilname": "Chulalongkorn University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190", "affiliation-country": "Thailand"}, "coredata": {"srctype": "j", "eid": "2-s2.0-84954145694", "dc:description": "BACKGROUND: The Thai National Pharmacovigilance Center (NPVC) has operated since 1983, but its performance has never been formally assessed. OBJECTIVE: The paper aimed to present the main findings of performance assessment of the Thai NPVC. METHODS: A survey was conducted. Data from January 2011-December 2013 were collected. The performance was assessed through four indicator domains. RESULTS: The NPVC has a clear mission to guide its roles and responsibilities. The center has a well-established structure, adequate budget, qualified personnel, and good IT infrastructure, but it has no in-house IT personnel. Safety surveillance function was considered excellent. The Thai adverse drug reaction database accumulate a number of quality reports. Typically, new signals of traditional or herbal medicines could be generated from the database. The risk management process was well established and carried out. The National Drug Safety Advisory Sub-Committee was composed of qualified representatives from related disciplines. Not only do these committee members make safety decisions, but they also provide key safety messages and communicate these to their member audiences. The risk communication function was evaluated to be unsatisfactory. It was not effectively distributed to individual health care professionals. CONCLUSIONS: The overall performance of the Thai NPVC was considerably good. The findings suggested that risk communication should be improved. Moreover, organizational performance should be routinely evaluated. If possible, benchmarking with international pharmacovigilance centers should also be performed.", "pubmed-id": "26756896", "prism:coverDate": "2015-12-30", "prism:aggregationType": "Journal", "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/84954145694", "dc:creator": {"author": [{"ce:given-name": "Wanida", "preferred-name": {"ce:given-name": "Wanida", "ce:initials": "W.", "ce:surname": "Kaewpanukrungsi", "ce:indexed-name": "Kaewpanukrungsi W."}, "@seq": "1", "ce:initials": "W.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Kaewpanukrungsi", "@auid": "57053289400", "author-url": "https://api.elsevier.com/content/author/author_id/57053289400", "ce:indexed-name": "Kaewpanukrungsi W."}]}, "link": [{"@_fa": "true", "@rel": "self", "@href": "https://api.elsevier.com/content/abstract/scopus_id/84954145694"}, {"@_fa": "true", "@rel": "scopus", "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84954145694&origin=inward"}, {"@_fa": "true", "@rel": "scopus-citedby", "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84954145694&origin=inward"}], "source-id": "18161", "citedby-count": "4", "prism:volume": "27", "subtype": "ar", "dc:title": "Performance assessment of the Thai National Center for Pharmacovigilance", "openaccess": "0", "prism:issn": "18786847 09246479", "publishercopyright": "\u00a9 2015 IOS Press and the authors.", "prism:issueIdentifier": "4", "subtypeDescription": "Article", "prism:publicationName": "International Journal of Risk and Safety in Medicine", "prism:pageRange": "225-237", "prism:endingPage": "237", "openaccessFlag": "false", "prism:doi": "10.3233/JRS-150663", "prism:startingPage": "225", "dc:identifier": "SCOPUS_ID:84954145694", "dc:publisher": "IOS PressNieuwe Hemweg 6BAmsterdam1013 BG"}, "idxterms": {"mainterm": [{"$": "Adverse Drug Reaction Reporting Systems", "@weight": "b", "@candidate": "n"}, {"$": "Databases, Factual", "@weight": "b", "@candidate": "n"}, {"$": "Humans", "@weight": "b", "@candidate": "n"}, {"$": "Information Dissemination", "@weight": "b", "@candidate": "n"}, {"$": "Interviews as Topic", "@weight": "b", "@candidate": "n"}, {"$": "Observation", "@weight": "b", "@candidate": "n"}, {"$": "Patient Safety", "@weight": "b", "@candidate": "n"}, {"$": "Pharmacovigilance", "@weight": "a", "@candidate": "n"}, {"$": "Product Surveillance, Postmarketing", "@weight": "b", "@candidate": "n"}, {"$": "Program Evaluation", "@weight": "b", "@candidate": "n"}, {"$": "Risk Management", "@weight": "b", "@candidate": "n"}, {"$": "Thailand", "@weight": "b", "@candidate": "n"}]}, "language": {"@xml:lang": "eng"}, "authkeywords": {"author-keyword": [{"@_fa": "true", "$": "indicators"}, {"@_fa": "true", "$": "performance assessment"}, {"@_fa": "true", "$": "Pharmacovigilance (PV)"}, {"@_fa": "true", "$": "the Thai National Pharmacovigilance Center (Thai NPVC)"}]}, "subject-areas": {"subject-area": [{"@_fa": "true", "$": "Health Policy", "@code": "2719", "@abbrev": "MEDI"}, {"@_fa": "true", "$": "Public Health, Environmental and Occupational Health", "@code": "2739", "@abbrev": "MEDI"}]}, "authors": {"author": [{"ce:given-name": "Wanida", "preferred-name": {"ce:given-name": "Wanida", "ce:initials": "W.", "ce:surname": "Kaewpanukrungsi", "ce:indexed-name": "Kaewpanukrungsi W."}, "@seq": "1", "ce:initials": "W.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Kaewpanukrungsi", "@auid": "57053289400", "author-url": "https://api.elsevier.com/content/author/author_id/57053289400", "ce:indexed-name": "Kaewpanukrungsi W."}, {"ce:given-name": "Puree", "preferred-name": {"ce:given-name": "Puree", "ce:initials": "P.", "ce:surname": "Anantachoti", "ce:indexed-name": "Anantachoti P."}, "@seq": "2", "ce:initials": "P.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Anantachoti", "@auid": "6506845858", "author-url": "https://api.elsevier.com/content/author/author_id/6506845858", "ce:indexed-name": "Anantachoti P."}]}}}